ETHICAL COMPLIANCE REPORT

STRIDES PHARMA SCI

Sector:

Healthcare

Industry:

Drug Manufacturers - Specialty & Generic

Overall Compliance

non-compliant

PRIMARY BUSINESS FILTER
Pharmaceuticals
compliant
REVENUE RATIO FILTER
0.7%
View Calculations
DEBT RATIO FILTER
37%
View Calculations
LIQUIDITY RATIO FILTER
2.9%
View Calculations

Revenue Ratio

The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.

0.7%

Non Compliant

Questionable

Compliant

CALCULATION

\textbf{Revenue Ratio:} \\[12pt] \dfrac{304290000.00}{40908250000.00} \times 100 = 0.70\%

FORMULA

\textbf{Revenue Ratio:} \\[12pt] \dfrac{\text{Unethical Segments}}{\text{Total Revenue}} \times 100 \; \leq \; 3\%

Segment	Compliance	Value
Interest Income	non-compliant	₹29.64
Other Income	compliant	₹9.27
Investment Gain	questionable	₹0.79
Other Operating Revenue	compliant	₹160.10
Sale of Pharmaceuticals Products & Services	compliant	₹3,829.23
Sale of Services	compliant	₹61.79

Debt Ratio

The interest bearing debt should not exceed 31% of the total assets. This is to ensure that the company is not paying a significant portion of its assets as interest.

37%

CALCULATION

\textbf{Debt Ratio:} \\[12pt] \dfrac{22153780000.00}{59896290000.00} \times 100 = 37.00\%

FORMULA

\textbf{Debt Ratio:} \\[12pt] \dfrac{\text{Interest Bearing Debt}}{\text{Total Assets}} \times 100 \; \leq \; 30\%

Liquidity Ratio

The total liquid assets should not exceed 90% of the total assets. This is to ensure that trading this stock does not become similar to trading a currency.

2.9%

CALCULATION

\textbf{Liquidity Ratio:} \\[12pt] \dfrac{1755100000.00}{59896290000.00} \times 100 = 2.90\%

FORMULA

\textbf{Liquidity Ratio:} \\[12pt] \dfrac{\text{Total Liquid Assets}}{\text{Total Assets}} \times 100 \; \leq \; 90\%